Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn's disease - Université de Picardie Jules Verne Accéder directement au contenu
Communication Dans Un Congrès Année : 2019

Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn's disease

Florian Poullenot
  • Fonction : Auteur

Dates et versions

hal-03552299 , version 1 (02-02-2022)

Identifiants

Citer

Mathurin Fumery, Laurent Peyrin-Biroulet, Stéphane Nancey, Romain Altwegg, Pauline Veyrard, et al.. Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn's disease. 14. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2019, Copenhague, Denmark. ⟨10.1093/ecco-jcc/jjy222.023⟩. ⟨hal-03552299⟩
21 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More